Mingyuan He
The Third Clinical Medical College
Guangzhou Medical University
Mingyuan He is an undergraduate of The Third Clinical Medical College, Guangzhou Medical University in Guangzhou, China.
Dr He focused on the pathophysiology research of cardiovascular disease such as congestive heart failure, atherosclerosis, hypertension and aneurysm. As an undergraduate, he spared no effort in the study of the role of AMP dependent protein kinase (AMPK) and myosin light chain kinase (MLCK) in the development of congestive heart failure in the Translational Research Centre of Regenerative Medicine University, The third Affiliated Hospital of Guangzhou Medical University. And then he moved to the State Key laboratory of Organ Failure Research,Nanfang Hospital to use the model of transverse aortic constriction to continue his research in AMPK and MLCK.
[Metformin inhibits aortic atherosclerosis in mice by regulating actin skeleton in vascular smooth muscle cells].
Nan fang yi ke da xue xue bao = Journal of Southern Medical University Nov, 2019 | Pubmed ID: 31852643
Metformin Suppresses the Progress of Diabetes-Accelerated Atherosclerosis by Inhibition of Vascular Smooth Muscle Cell Migration Through AMPK-Pdlim5 Pathway.
Frontiers in cardiovascular medicine , 2021 | Pubmed ID: 34368251
Response by He et al to Letter Regarding Article, "Antihypertrophic Memory After Regression of Exercise-Induced Physiological Myocardial Hypertrophy Is Mediated by the Long Noncoding RNA Mhrt779".
Circulation 10, 2021 | Pubmed ID: 34662156
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。